The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2017

Filed:

Apr. 14, 2014
Applicants:

Jeffery W Kelly, LaJolla, CA (US);

Sungwook Choi, Yuseong-gu Drejeon, KR;

Inventors:

Jeffery W Kelly, LaJolla, CA (US);

Sungwook Choi, Yuseong-gu Drejeon, KR;

Assignee:

THE SCRIPPS RESEARCH INSTITUTE, La Jolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/21 (2006.01); C07C 327/26 (2006.01); A61K 31/136 (2006.01); C07C 39/21 (2006.01); C07C 65/19 (2006.01); C07C 69/94 (2006.01); C07C 205/43 (2006.01); C07C 229/64 (2006.01); C07C 237/30 (2006.01); C07C 245/08 (2006.01); C09B 23/14 (2006.01); C09B 29/01 (2006.01); C09B 29/036 (2006.01); C09B 29/033 (2006.01); C09B 29/10 (2006.01); C09B 29/12 (2006.01); G01N 33/68 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
C07C 327/26 (2013.01); A61K 31/136 (2013.01); C07C 39/21 (2013.01); C07C 65/19 (2013.01); C07C 69/94 (2013.01); C07C 205/43 (2013.01); C07C 229/64 (2013.01); C07C 237/30 (2013.01); C07C 245/08 (2013.01); C09B 23/14 (2013.01); C09B 23/145 (2013.01); C09B 23/146 (2013.01); C09B 23/148 (2013.01); C09B 29/0007 (2013.01); C09B 29/0014 (2013.01); C09B 29/0029 (2013.01); C09B 29/0048 (2013.01); C09B 29/0051 (2013.01); C09B 29/0055 (2013.01); C09B 29/0059 (2013.01); C09B 29/0066 (2013.01); C09B 29/0085 (2013.01); C09B 29/10 (2013.01); C09B 29/12 (2013.01); G01N 33/6896 (2013.01); G01N 33/74 (2013.01); G01N 2333/4709 (2013.01); G01N 2500/04 (2013.01);
Abstract

A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and reacts chemoselectively with one or two of four Lys-15 ε-amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.


Find Patent Forward Citations

Loading…